May 7th, 2015
Advocates Say Precision Medicine Could Lead to Enormous Benefits
Larry Husten, PHD
Personalized and precision medicine (PPM) could deliver hundreds of billions of dollars worth of improved health in the next 50 years in the United States, writes Victor Dzau, the new president of the Institute of Medicine, and coauthors in a Viewpoint published in the Lancet. The authors used a health simulation model to estimate the effect of […]
July 1st, 2013
Selections from Richard Lehman’s Literature Review: July 1st
Richard Lehman, BM, BCh, MRCGP
This week’s topics include studies on aggressive fluid and sodium restriction in acute decompensated HF, the yield of routine cardiac testing in an ED-based chest pain unit, and more.
March 6th, 2012
Another Round in the Debate on Diabetes and Statins
Yoni Freedhoff, MD
Let me start by saying that I am proud to have Eric Topol as a friend and a trusted advisor over the past 20 years. His work has been an inspiration to cardiovascular health professionals for several decades. His new book, The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care, […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?